Osilodrostat vs Trastuzumab
Osilodrostat vs Trastuzumab: Overview
This comparison examines the pharmacological differences between Osilodrostat and Trastuzumab.
Mechanism of Action
Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.
Pharmacokinetics
Half-life: Trastuzumab — 28 days.
Chemical Properties
Type: Osilodrostat — Small molecule; Trastuzumab — Antibody.